Clinical Profile and Outcomes of Acute Myeloid Leukemia: An Institutional Experience from South India
Journal Title: Indian Journal of Cancer Education and Research - Year 2019, Vol 7, Issue 2
Abstract
Background: Acute myeloid leukemia is a heterogenous clonal disorder of hematopoietic progenitor cells with different molecular genetic abnormalities, clinical characteristics and variable outcomes with currently available treatment. Aim of the study is to analyse the clinical profile & outcomes of AML, an institutional experience where BMT facility is not available. Aims: Clinical profile and outcomes of Acute myeloid leukemia is evaluated. Material and Methods: Retrospective chart review of 51 patients diagnosed of AML with clinical and therapeutic data analysed. Results: 51 patients were analysed (males 30, females 21) with a male predominance. 90% (46/51) of patients were in the age group of <60 yrs & nearly 40% (20/51) were 15–30 yrs which is significant. M2 was the most common FAB subtype with 23/51 (45%) cases and most common presentation is fever. The observed average baseline parameters were: Hb of 6–8 gr% with 30% showed <6 gr%,TLC >15,000 in 90% of cases which confer poor outcomes (60% cases – >50,000 and 30% – >1 lakh). The average platelet count was 20,000–40,000 (25% cases – <20,000). Most patients had a baseline blasts% of >70. The average number of transfusions required during induction were in the range of (PRBCs-4–6, RDPs-20–30, SDPs-2–4 & overall 25–35). Among 51 patients, approxly 75% (38/51) were treated with intensive chemotherapy and 13 were on BSC. Remission rate was found to be 42% (16/38) in patients who received induction chemotherapy while >95% of them relapsed. As most of the patients were not on follow up or died, no follow up data was found to calculate the survivals. Conclusions: AML is an aggressive malignancy with poor outcomes and high relapse rates, especially without BMT. Supportive care constitutes a major component of management. As most of the patients were presenting very late and in poor PS (bad parameters at baseline) early aggressive treatment with strong supportive care improve the cure rates and survival.
Authors and Affiliations
Venkatesh Mushini
Keywords
Related Articles
- EP ID EP668617
- DOI 10.21088/ijcer.2321.9815.7219.7
- Views 110
- Downloads 0
Microbiological Analysis of Hospital Acquired Infections in Burn Patients
Introduction: About 75% of the mortality associated with burn injuries is related to sepsis, especially in developing countries. Since it is desirable to carry out periodic reviews of bacterial flora of burn wounds and e...
Can Accurate Pre Operative Assessment of Axillary Lymph Node in Breast Cancer Avoid Axillary Dissection?
Background: The Axillary Lymph node status is of paramount importance in staging, treatment planning, prognosis and survival in Breast Cancer. Hence appropriate investigating criteria for AXLN assessment, which is easy,...
Carcinoma Oesophagus with Subcutaneous Metastasis: A Rare Case Report
Metastases to skin from primary internal malignancies are rare with the incidence ranging from 0.7% to 10%. Cutaneous metastasis are frequently found in melanoma, breast cancer, or mucosal cancers of the head and neck. S...
Hypoxia Inducible Factor-1 (HIF-1) and Cancer Progression: A Comprehensive Review
Hypoxia is characterized as a decrease oxygen levels in tissue, represents a fundamental pathophysiological condition in the microenvironment of solid tumors. The key component of hypoxia sensing in the cell is the hypox...
Malignant Melanoma of Anorectum with Liver Metastasis: A Case Report
Anal melanoma is an uncommon and very aggressive cancer. Different surgical techniques have been used to manage this disease with no clear favour of one approach over the another. We saw one patient with a mass in anal r...